Comments
Pharma major >Dr Reddy’s Laboratories is recalling its muscle relaxant tizanidine tablets from the US market due to labelling issues.
The recall was initiated voluntarily by the Hyderabad-based company, as per an intimation from the company to the US Food and Drug Administration.
Over 1.17 lakh bottles are being recalled from the market. Each bottle has 150 tablets.
As per the US regulator, the recall is dubbed as class III recall, in which adverse health impact is unlikely.
Dr Reddy’s scrip gained 0.54 per cent on the Bombay Stock Exchange and is trading at Rs 1,897 by the lunch hour on Friday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.